Status:
COMPLETED
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli
Lead Sponsor:
Skaraborg Hospital
Collaborating Sponsors:
Karolinska University Hospital
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The primary objectives of this study were to characterize lactobacilli of human vaginal origin and to investigate if more extended antibiotic treatment against Bacterial Vaginosis, together with adjuv...
Detailed Description
Nine of the vaginal Lactobacillus strains isolated from healthy Swedish women and characterized in the present study were selected for the clinical trial.All women with symptomatic BV fulfilling the i...
Eligibility Criteria
Inclusion
- were regularly menstruating women, 18 years or older, with normal gynaecological status, not pregnant or breast-feeding and without signs of other genital tract infections.
Exclusion
- Exclusion criteria were patients with hormonal IUD without regular menstruation; women infected with Chlamydia trachomatis or with Trichomonas vaginalis, or with a clinical candida infection
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01245322
Start Date
January 1 2007
End Date
October 1 2014
Last Update
November 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynekologklinikken
Drammen, Norway, 3002